Thegrowing biopharma industry in China has resulted in the creation of lucrativebusiness opportunities for contract service providers; region-specificadvantages have also attracted several foreign sponsors entities over the lastfew years
RootsAnalysis is pleased to announce the publication of its recent study, titled, “China Biopharmaceutical ContractManufacturing Market, 2020-2030.”
Thereport features an extensive study of the current market landscape and futureopportunities associated with the contract manufacturing of biopharmaceuticalsin China. The study also features a detailed analysis of key drivers and trendsrelated to this evolving domain. In addition to other elements, the studyincludes:
· A detailed assessment of the current market landscapeof companies offering contract manufacturing services for biopharmaceuticals inChina.
· An analysis of the partnerships that havebeen established in this domain, in the recent past.
· An analysis of the expansion initiativesundertaken by contract manufacturers in China, in order to augment theircapabilities, in the recent past.
· A detailed analysis of more than 1500clinical trials related to biopharmaceuticals that have been / are being / arelikely to be conducted in China.
· An estimate of the overall, installedcapacity for manufacturing biopharmaceuticals, based on data reported byindustry stakeholders in the public domain.
· An analysis of the initiatives of bigbiopharma players engaged in this domain.
· A qualitative analysis, highlighting the variousfactors that need to be taken into consideration by drug / therapy developerswhile deciding whether to manufacture their respective products in-house orengage the services of a CMO.
· Detailed profiles of key players that have adiverse range of capabilities for the development, manufacturing, and packagingof biopharmaceutical products.
· A case study comparing the keycharacteristics of large molecule and small molecule drugs.
· A discussion on industry affiliated trends,key drivers, and challenges, under a SWOT framework, which are likely to impactthe evolution of this field.
Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)
Typeof Product
· API
· FDF
Typeof Expression System Used
· Mammalian
· Microbial
· Others
Scaleof Operation
· Preclinical / Clinical
· Commercial
Sizeof Manufacturer
· Small
· Mid-sized
· Large / Very Large
Typeof Biologic
· Antibody
· Vaccine
· Others
Keycompanies covered in the report
· ChemPartner Biologics
· JHL Biotech
· JOINN Biologics
· MabPlex
· Mycenax Biotech
· WuXi AppTec
Formore information, please click on the following link:
AboutRoots Analysis
RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
ContactInformation
RootsAnalysis Private Limited
GauravChaudhary
+1(415) 800 3415
